Patent · US Active

1-oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors in the treatment of cancers

US9776992B2 · kind B2 · utility

0Cited by

1References

8Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Harold Burns Brooks · Carmel, US
Robert Dally · Indianapolis, US
Timothy Barrett Durham · Indianapolis, US
Kevin Robert Fales · Avon, US
Kwame Frimpong · Indianapolis, US
Jefferson Ray McCowan · Indianapolis, US
Frank George Njoroge · Carmel, US
Timothy Alan Shepherd · Indianapolis, US
Chong SI · Brookline, US
Kenneth Jeff Thrasher · Indianapolis, US
James Lee Toth · Knightstown, US
Zhipei Wu · Fishers, US

Key dates

Filing date	Nov 24, 2015
Grant date	Oct 3, 2017
Priority date	—
Expiry date	Nov 24, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

1-Oxo-1,2-dihydroisoquinolin-7-yl-(5-substituted-thiophen-2-yl)-sulfonamide compounds, formulations containing those compounds, and their use as AICARFT inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.